EUVIMED · CrossrefZeitschrift
EJC Skin Cancer
ISSN 2772-6118 · Elsevier BV
Neueste Artikel
Modality-Specific Prognostic and Predictive Factors in Metastatic Uveal Melanoma
BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study
PD-L1 assessment in Merkel cell carcinoma: Predictive implications for anti-PD-1 and anti-PD-L1 therapy
The survivorship experience of people with stage II-IV melanoma receiving adjuvant therapy: A real-world, prospective, longitudinal study
Ten-year outcomes after initial response to immune checkpoint inhibitors in patients with advanced Merkel cell carcinoma
Influence of dosage and therapeutic interval on the incidence of severe side effects of immunotherapy with PD-1 inhibitors in malignant melanoma
Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations
Locally advanced basal cell carcinoma in real life: Analysis of a cohort of 452 patients treated with systemic therapy from the CARADERM database
Machine learning algorithms using dermatoscopy for the prediction of melanoma prognosis: A narrative review of the literature
Adjuvant systemic therapy in melanoma: Relative versus absolute benefit; the number needed to treat (NNT) versus the number needed to harm (NNH)?
Quality of life issues faced by patients with keratinocyte cancer: A systematic review
Neoadjuvant Vismodegib plus Mohs surgery for locally advanced periocular basal cell carcinoma. Real world scenario
European Journal of Skin Cancer Editorial
Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin
Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study
German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023
CLAUDIUS Study: Risk of materno-fetal transmission of melanoma cells in pregnant women with high grade melanoma – A retrospective multicenter study and literature review
Management of patients with skin adnexal carcinomas
Real-world data on tolerability and clinical response of cemiplimab in patients with advanced cutaneous squamous cell carcinoma: A retrospective, multicentre cohort study from the Netherlands
A systematic review of economic evaluations for the interventions of superficial basal cell carcinoma
Lack of response to midostaurin in a patient with vulvar melanoma harboring an unusual KIT D816Y mutation that emerged after a previous treatment with imatinib
Metastatic amelanotic malignant melanoma in a patient with oculocutaneous albinism: A rare presentation
Histologic and genomic characterization of a primary mucinous carcinoma of the skin
Spontaneous haematoma: A unique immune-related adverse event alongside other cutaneous reactions in a patient treated with pembrolizumab for metastatic melanoma
Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders
Preoperative evaluation of high-risk basal cell carcinoma with line-field confocal optical coherence tomography (LC-OCT) reduces Mohs micrographic surgery stage number: A case-control study
Line-field confocal optical coherence tomography (LC-OCT) features of a melanotic macule of the lip
Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort study
Merkel cell carcinoma with leptomeningeal involvement: A complex case report
Diagnostic challenges of posterior scleritis in pembrolizumab treated patient for cutaneous melanoma: A case report
EUVIMED